Diario de Farmacovigilancia

Artículo de revisión

A Review on Adverse Drug Events to Create Awareness

• Pallavi Jaiswal

Artículo de investigación

The Use of Angiotensin Converting Enzyme Inhibitors during the First Trimester of Pregnancy

• Lyn Colvin, Barry NJ Walters, Andrew W Gill, Linda Slack-Smith, Fiona J Stanley, Lolkje TW De Jong-Van De Berg and Carol Bower

Comunicación corta

Global Health Systems

• Jack Warren Salmon

Carta de investigación

Bayesian Approach to Urinary ESBL-Producing Escherichia coli

• osé Miguel Sahuquillo-Arce, Hèctor Perpiñán, Carmen Armero, Antonio López-Quílez, María Selva and Francisco González

Reporte de un caso

Chronic Hepatitis C (CHC) Treatment in Two Cystic Fibrosis (CF) Patients

• Marianna Passiu, Ilaria Meneghelli and Baroukh Maurice Assael

Artículo de investigación

Motivations and Obstacles for Adverse Drug Reactions Reporting among Healthcare Professionals from the Perspective of Lewin’s Force Field Analysis Theory: Analytic Approach

• Ramadan M Elkalmi, Omar Q Al-lela and Shazia Q Jamshed

Artículo de investigación

Clinical Pharmacist Driven Impact towards Intensive Monitoring and Reporting of Adverse Drug Events in Psychiatric Patients

• Disha A Khoda, Madiwalayya S Ganachari, Tarun Wadhwa, Shashikala Walli, Bhupendra Parihar and Atul Aggarwal